Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

SAGE THERAPEUTICS, INC.

(SAGE)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť SAGE THERAPEUTICS, INC.
29/11Sage Therapeutics to Host Sage FutureCast Webcast
BU
24/11Sage Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Confer..
BU
11/11Sage Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference
BU
02/11Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipelin..
PU
02/11SAGE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
02/11Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipelin..
BU
20/10SAGE THERAPEUTICS : to Report Third Quarter 2021 Financial Results on Tuesday, November 2,..
BU
20/10SAGE THERAPEUTICS : and Biogen Announce Plans to Submit a New Drug Application (NDA) for Z..
AQ
19/10SAGE THERAPEUTICS : and Biogen Announce Plans to Submit a New Drug Application (NDA) for Z..
PU
19/10SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/10SAGE THERAPEUTICS : and Biogen Announce Consistent Clinically Meaningful Data for Zuranolo..
BU
01/10SAGE THERAPEUTICS : Launches SageCitizen Social Impact Initiative
BU
21/09SAGE THERAPEUTICS : Appoints Chris Benecchi as Chief Commercial Officer
BU
16/09SAGE THERAPEUTICS : Receives Fast Track Designation for SAGE-718 for the Treatment of Hunt..
AQ
15/09SAGE THERAPEUTICS : Receives Fast Track Designation for SAGE-718 for the Treatment of Hunt..
BU
02/09SAGE THERAPEUTICS : to Present at the Morgan Stanley Global Healthcare Conference
BU
04/08SAGE THERAPEUTICS : to Present at Upcoming August Investor Conferences
BU
03/08SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
03/08SAGE THERAPEUTICS : Company announces REDWOOD and RAINFOREST Studies not expected to be re..
PU
03/08SAGE THERAPEUTICS : Announces Second Quarter 2021 Financial Results and Highlights Pipelin..
BU
20/07SAGE THERAPEUTICS : to Report Second Quarter 2021 Financial Results on Tuesday, August 3, ..
BU
09/07SAGE THERAPEUTICS : to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsyc..
AQ
08/07SAGE THERAPEUTICS : to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsyc..
BU
25/06SAGE THERAPEUTICS : to Participate in SVB Leerink's 3rd Annual CNS Forum
AQ
24/06SAGE THERAPEUTICS : to Participate in SVB Leerink's 3rd Annual CNS Forum
BU
17/06Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone f..
AQ
16/06SAGE THERAPEUTICS : and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone an..
AQ
15/06Cracker Barrel, Sage Therapeutics fall; Ocugen, FedEx rise
AQ
15/06SAGE THERAPEUTICS : to Host Conference Call
BU
15/06SAGE THERAPEUTICS : and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, a..
PU
15/06SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/06SAGE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
20/05SAGE THERAPEUTICS : Joins MTV Entertainment Group and More Than 1,300 Leading Organization..
BU
13/05SAGE THERAPEUTICS TO HOST SAGE SCIEN : SAGE-718 In Depth
BU
04/05SAGE THERAPEUTICS : Company on-track to initiate placebo-controlled Phase 2 trial with SAG..
PU
04/05SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
04/05SAGE THERAPEUTICS : Announces First Quarter 2021 Financial Results and Highlights Pipeline..
BU
28/04SAGE THERAPEUTICS : to Present at Upcoming May Investor Conferences
BU
20/04SAGE THERAPEUTICS : to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021
BU
12/04SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
24/03SAGE THERAPEUTICS : to Present at the Stifel 3rd Annual CNS Day
BU
18/03SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
17/03SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
17/03SAGE THERAPEUTICS : Announces Continued Positive Zuranolone Data for Both 30 mg and 50 mg ..
BU
16/03SAGE THERAPEUTICS : Announces Departure of Chief Operating Officer
BU
24/02SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
24/02SAGE THERAPEUTICS : Announces Fourth Quarter and Full Year 2020 Financial Results and High..
BU
11/02SAGE THERAPEUTICS : to Present at Upcoming Investor Conferences
BU
10/02SAGE THERAPEUTICS : to Report Fourth Quarter and Full Year 2020 Financial Results on Wedne..
BU
07/01SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Other Events, Fin..
AQ
07/01SAGE THERAPEUTICS : Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare Conf..
BU
2020SAGE THERAPEUTICS, INC. : Other Events (form 8-K)
AQ
2020SAGE THERAPEUTICS : to Present at the 39th Annual J.P. Morgan Healthcare Conference on Tue..
BU
2020SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020SAGE THERAPEUTICS : Announces the Appointment of Barry Greene as CEO
BU
2020SAGE THERAPEUTICS : to Present at BMO 2020 Growth and ESG Conference
AQ
2020SAGE THERAPEUTICS : to Present at BMO 2020 Growth & ESG Conference
BU
2020BIOGEN : and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize ..
AQ
2020SAGE THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of..
AQ
2020BIOGEN : and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize ..
AQ
2020SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
2020SAGE THERAPEUTICS : Announces Third Quarter 2020 Financial Results and Highlights Pipeline..
BU
2020SAGE THERAPEUTICS : to Present at Upcoming November Investor Conferences
AQ
2020SAGE THERAPEUTICS : to Present at Upcoming November Investor Conferences
BU
2020SAGE THERAPEUTICS : Announces Chief Executive Jeff Jonas to Undergo Scheduled Medical Proc..
AQ
2020SAGE THERAPEUTICS : Announces Chief Executive Jeff Jonas to Undergo Scheduled Medical Proc..
BU
2020SAGE THERAPEUTICS : to Report Third Quarter 2020 Financial Results on Thursday, November 5..
AQ
2020SAGE THERAPEUTICS : to Report Third Quarter 2020 Financial Results on Thursday, November 5..
BU
2020SAGE THERAPEUTICS : Announces Positive Interim, Topline Zuranolone Safety and Tolerability..
AQ
2020SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020SAGE THERAPEUTICS : Announces Positive Interim, Topline Zuranolone Safety and Tolerability..
BU
2020SAGE THERAPEUTICS : Appoints Barry Greene to Board of Directors
AQ
2020SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events, Financi..
AQ
2020SAGE THERAPEUTICS : Appoints Barry Greene to Board of Directors
BU
2020SAGE THERAPEUTICS : rsquo; FutureCast to Provide Update on Pipeline Progression and Additi..
BU
1  2  3  4  5Volgende
Volgende evenement op SAGE THERAPEUTICS, INC.
23/02/22